Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
37 hedge funds and large institutions have $90.5M invested in Marrone Bio Innovations, Inc. in 2013 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$14M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$13.1M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$12.6M |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$8.37M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$6.32M |
Top Sellers
MBII Hedge Fund Activity: Q3 2013 in Review
37 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2013, worth a combined $90.5M.
Buyers outnumbered sellers: 37 funds opened new MBII positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $14M.
- 37 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $90.5M of Marrone Bio Innovations, Inc. stock for Q3 2013.
- 37 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2013 and 0 closed out, a net change of +37 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2013 was Waddell & Reed Financial, an estimated $14M added.
Based on aggregated 13F filings for Q3 2013.